By Jennifer Ahlstrom | Posted - Sep 1st, 2016





November 19, Myeloma Crowd Round Tables: Minneapolis, Minnesota

Register Now Myeloma Crowd Round Tables are day-long meetings that provide patients and caregivers updated information so that they are able to make decisions about their treatment and care. Intended to go beyond "Myeloma 101" they help patients answer key questions: What should myeloma patients do at relapse? Or when they become refractory to treatments? Learn from top myeloma experts about relapsed and high-risk disease and what you can do to stay one step ahead for your best outcomes. This is a great opportunity to ask your questions and meet others in the myeloma community. Topics will include:

  • Diagnosing Low- and High-Risk Disease
  • Myeloma Genomics and How They Evolve During Treatment
  • Chromosomal Translocations and other High-Risk Features
  • Transplantation Issues of Low- and High-Risk Disease
  • Monoclonal Antibodies and Immunotherapy
  • Strategies for Refractory and Relapsed Patients
  • Demystifying Clinical Trials

Saturday, November 19, 2016 Time: Registration begins at 8:00 am. Session runs from 9:00 am - 4:00 pm Site:

  • Minneapolis Marriott Northwest, 7025 Northland Dr. Brooklyn Park, MN 55428
  • If you want to book a room, call 763-536-8300 and request the Myeloma Crowd rate of $109 per night.
  • Closest airport is Minneapolis-St. Paul International Airport (MSP)

 Registration is $25 per person. (Please contact if you require additional financial assistance) Faculty:

  • Morie Gertz, MD, Mayo Clinic (Host)
  • Guido Tricot, MD, PhD, University of Iowa
  • Brian Van Ness, PhD, University of Minnesota


Jennifer Ahlstrom
About the Author

Jennifer Ahlstrom - Jenny A - Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can help accelerate a cure by weighing in and participating in clinical research. Founder of Myeloma Crowd by HealthTree and the HealthTree Foundation.


Add a Comment



Thanks to our Myeloma Crowd Community sponsors:

.                         .       .